Business

The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance

CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2025. Recent Operational Highlights Retail Pharmacy and Dispensary set fill records, contributing $49.3 million revenue and over $9 million in gross profit in Q1. The Pharmacy and Dispensary segment grew over 20% in the first quart

articleThe Oncology Institute, Inc.May 14, 202519/company/oncology-institute-inc/news/oncology-institute-reports-first-quarter-200600102
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance

About this update from The Oncology Institute, Inc.

[{"type":"image","alt":"Toi Management, LLC","displaySize":"","headline":null,"caption":"Toi Management, LLC","className":"","disableSlideshowImg":false,"size":{"original":{"width":248,"height":86,"url":"https://media.zenfs.com/en/globenewswire.com/38271848c3d8a5e1e22cde43512eba2e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yhdVXLCOU06mfTSW3.iIsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/38271848c3d8a5e1e22cde43512eba2e","width":248,"height":86}},"lazy":false},{"type":"text","content":"CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2025.","length":279,"tagName":"p"},{"type":"text","content":"Recent Operational Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Retail Pharmacy and Dispensary set fill records, contributing $49.3 million revenue and over $9 million in gross profit in Q1. The Pharmacy and Dispensary segment grew over 20% in the first quarter of 2025 vs. prior year","length":220,"tagName":"p"}]},{"val":[{"type":"text","content":"Fee-for-service growth of 9% in Q1 2025 over Q4 2024, highlighting the impact of our investments in referral relationship management and call center expansion.","length":159,"tagName":"p"}]},{"val":[{"type":"text","content":"Strong start to 2025 with multiple capitated contract wins, adding over 100,000 lives, which will ramp in the first and second quarters of 2025 on four agreements across the Florida, California and Nevada markets","length":212,"tagName":"p"}]},{"val":[{"type":"text","content":"Started first fully-delegated capitation agreement with a major health plan in Florida on March 1 with delegation for Utilization Management and Claims and Network","length":163,"tagName":"p"}]},{"val":[{"type":"text","content":"Signed a new capitation contract in Nevada during the first quarter, which adds over 80,000 Medicaid lives to Clark County with an effective date of July 1","length":160,"tagName":"p"}]},{"val":[{"type":"text","content":"Started a contract with a new California-based IPA within a geography where TOI has a strong presence","length":101,"tagName":"p"}]},{"val":[{"type...

More updates from The Oncology Institute, Inc.

TOIFree Cash flowThe Oncology Institute, Inc.Cash and cash equivalentsFinancial Measures